RWS Holdings PLC
02 February 2005
2 February 2005
RWS Holdings plc
£2.25 million acquisition of Eclipse Translations Limited
RWS Holdings plc ('RWS'), the AIM listed intellectual property support services
provider is pleased to announce the acquisition of the entire issued share
capital of Eclipse Translations Limited ('Eclipse') for a total cash
consideration of £2.25M.
Eclipse, based in Alnwick, Northumberland, operates from purpose-built secure
offices, cleared for highly secret Government work, and is a leading translator
in the Medical and Defence sectors. Key contractual clients include the MOD, UK
Hydrographic Office and Eurojust.
Eclipse's latest audited financial statements for the year ended 30 September
2004 show net assets of £454,000, turnover of £1,538,000 and adjusted profit
before tax of £326,000.
Eclipse will provide RWS with secure long-term contracts and a profitable
expansion of its non patent business.
Andrew Brode, Executive Chairman of RWS said:
'We are pleased to be adding the cost competitive Eclipse brand and its
excellent team to our Group. This acquisition will be immediately earnings
enhancing and will further underline RWS' position as Europe's leading technical
translations provider.'
- Ends -
For further information contact:
RWS Holdings plc
Andrew Brode, Executive Chairman 01753 480200
Weber Shandwick Square Mile
Nick Oborne 020 7067 0721
About RWS:
RWS is the leading provider of intellectual property support services (patent
translations and technical searches to the medical, pharmaceutical, chemical,
aerospace, defence, automotive and telecoms industries). RWS also provides
specialist technical, legal and financial translation services for areas of
industry outside the patent arena. RWS is based in the UK with offices in
Europe, New York and Tokyo.
For further information please visit: www.rws.com
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.